Literature DB >> 8353889

Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction.

Y Liu1, J D Thornton, M V Cohen, J M Downey, S W Schaffer.   

Abstract

BACKGROUND: The vulnerability of the myocardium of a diabetic animal to an ischemic insult is controversial. To address this issue, streptozotocin-induced non-insulin-dependent diabetes (NIDD) was induced in rats, and the effects of regional myocardial ischemia were assessed by measuring infarct size. METHODS AND
RESULTS: Open-chest rats with NIDD and age-matched control rats underwent 30 or 45 minutes of regional ischemia and 2-hour reperfusion. Infarct size was measured by tetrazolium. Control rats had 32.0 +/- 3.3% infarction of the risk zone after a 30-minute coronary occlusion, whereas NIDD rats had significantly smaller infarcts (11.5 +/- 3.1% of the risk area, P < .005). When ischemic time was extended to 45 minutes, infarct size in control animals averaged 57.9 +/- 6.2%, whereas only 37.3 +/- 5.6% of ischemic myocardium was infarcted in NIDD rats (P < .05). In a subset NIDD group, rats experienced a period of ischemic preconditioning (three cycles of 5-minute ischemia/5-minute reperfusion) before 45-minute ischemia. Infarct size in these rats averaged only 6.9 +/- 3.0% (P < .01 vs nonpreconditioned NIDD rats with 45-minute coronary occlusions). Collateral flow was measured in NIDD rat hearts with radioactive microspheres. Collateral flow was < 1% of normal myocardial blood flow.
CONCLUSIONS: We conclude that NIDD protects the heart from infarction and that this protection is not related to the development of coronary collaterals. Furthermore, preconditioning can further protect the NIDD heart.

Entities:  

Mesh:

Year:  1993        PMID: 8353889     DOI: 10.1161/01.cir.88.3.1273

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia.

Authors:  Michael P Robich; Robert M Osipov; Louis M Chu; Yuchi Han; Jun Feng; Reza Nezafat; Richard T Clements; Warren J Manning; Frank W Sellke
Journal:  Eur J Pharmacol       Date:  2011-05-07       Impact factor: 4.432

2.  Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes.

Authors:  Karin Przyklenk; Michelle Maynard; Dale L Greiner; Peter Whittaker
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

3.  Hyperoxia-induced cardiotoxicity and ventricular remodeling in type-II diabetes mice.

Authors:  Jennifer Leigh Rodgers; Eva Samal; Subhra Mohapatra; Siva Kumar Panguluri
Journal:  Heart Vessels       Date:  2017-12-05       Impact factor: 2.037

Review 4.  Metabolic abnormalities in the diabetic heart.

Authors:  Gary D Lopaschuk
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

5.  Subcellular mechanisms of adaptation in the diabetic myocardium: Relevance to ischemic preconditioning in the nondiseased heart.

Authors:  T Ravingerová; A Adameová; J Matejíková; T Kelly; M Nemčeková; J Kucharská; O Pecháňová; A Lazou
Journal:  Exp Clin Cardiol       Date:  2010

6.  Acute diabetes modulates response to ischemia in isolated rat heart.

Authors:  T Ravingerova; R Stetka; K Volkovova; D Pancza; A Dzurba; A Ziegelhöffer; J Styk
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

7.  Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes.

Authors:  S B Kristiansen; B Løfgren; N B Støttrup; D Khatir; J E Nielsen-Kudsk; T T Nielsen; H E Bøtker; A Flyvbjerg
Journal:  Diabetologia       Date:  2004-10-07       Impact factor: 10.122

8.  Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo.

Authors:  Dirk Ebel; Jost Müllenheim; Jan Frässdorf; Andre Heinen; Ragnar Huhn; Thomas Bohlen; Jan Ferrari; Hendrik Südkamp; Benedikt Preckel; Wolfgang Schlack; Volker Thämer
Journal:  Pflugers Arch       Date:  2003-03-26       Impact factor: 3.657

9.  Targeted Modification of Mitochondrial ROS Production Converts High Glucose-Induced Cytotoxicity to Cytoprotection: Effects on Anesthetic Preconditioning.

Authors:  Filip Sedlic; Maria Y Muravyeva; Ana Sepac; Marija Sedlic; Anna Marie Williams; Meiying Yang; Xiaowen Bai; Zeljko J Bosnjak
Journal:  J Cell Physiol       Date:  2016-06-21       Impact factor: 6.384

10.  Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats.

Authors:  Jiung-Pang Huang; Shiang-Suo Huang; Jen-Ying Deng; Li-Man Hung
Journal:  J Biomed Sci       Date:  2009-08-25       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.